ARK THER GRP

(AKT GB0034251727 GBX)
Value 2.875
Change Today +0.15 Trend icon
Updated17/05 16:35
TRADE NOWTrade now icon
WATCHLISTWatchlist icon
ALERTSAlerts icon
Chart timeline icon candlestick graph icon line graph icon Intraday technical chart icon Historical technical chart icon

PROFILE

Registered Number 04313987
Registered Address 79 New Cavendish Street
London
W1W 6XB
Phone Number +44 (0) 207 3887722
Fax Number
Website http://www.arktherapeutics.com
Activities Discovers develops and commercialize specialist medicine
Country of Register GB
Currency GBX
Short Name ARK THER GRP
First Day Traded 08/07/2005
Industrial Sector Biotechnology
Number of shares 209m

Key People

Andrew Christie Chairman
Iain Ross Chairman
Martyn Williams Chief Executive Officer
Nigel Parker Chief Executive Officer
Seppo Yla-Herttuala Non Executive Director
Charles Spicer Non Executive Director
David Bloxham Non Executive Director

Major Shareholders

Aberforth Partners LLP 18.09%
Smith & Williamson Investment Management Ltd. 12.06%

Director Deals

Director Date Buy/Sell Quantity Price

You need to be a Selfrade customer to access this data.

Find out more >

Income Statements £1K

hide content

AR 2007AR 2008AR 2009AR 2010AR 2011
Fiscal Year End31/12/200731/12/200831/12/200931/12/201031/12/2011
Duration (months)1212121212
Accounting FormatIFRSIFRSIFRSIFRSIFRS
Sales/Revenue1.130.932.960.767.13
Cost of Goods Sold (COGS) incl. D&A1.392.004.103.173.02
  COGS excluding D&A0.370.481.040.300.41
  Depreciation & Amortization Expense1.021.523.062.872.62
    Depreciation0.730.652.102.502.31
    Amortization of Intangibles0.290.870.970.360.31
    Amortization of Deferred Charges00000
Gross Income-0.27-1.07-1.14-2.414.11
Selling, General & Administrative Expense22.4422.8719.9112.588.86
  Research & Development14.6116.4615.5610.857.68
  Other Selling, General & Administrative7.836.404.351.741.19
Other Operating Expense000.010.670
Non Operating Income/Expense2.655.660.170.510.37
Non-Operating Interest Income00000
Equity in Affiliates (Pretax)00000
EBIT00000
Unusual Expense0-0.610.231.750
EBIT after Unusual Expense00000
Interest Expense0.030.040.030.020.06
  Gross Interest Expense0.030.040.030.020.06
  Interest Capitalized00000
Pretax Income-20.02-17.60-21.15-16.94-4.44
Income Tax-1.84-1.72-1.29-1.03-0.71
  Income Tax - Current Domestic-1.86-1.72-1.31-1.03-0.71
  Income Tax - Current Foreign0.020.000.03-0.010
  Income Tax - Deferred Domestic00000
  Income Tax - Deferred Foreign00000
  Income Tax Credits00000
Minority Interest Expense00000
Equity in Affiliates00000
Other After Tax Income (Expense)00000
Net Income-18.18-15.89-19.87-15.90-3.74
  Extraordinaries & Discontinued Operations000-0.270.29
    Extra Items & Gain/Loss Sale Of Assets00000.29
      Cumulative Effect - Accounting Chg00000
    Discontinued Operations000-0.270
Net Income After Extraordinaries-18.18-15.89-19.87-16.17-3.45
Preferred Dividends00000
Net Income available to Common-18.18-15.89-19.87-15.90-3.74
Operational EPS-10.75-7.95-9.51-7.02-1.79
EPS (basic)-11.00-8.00-10.00-7.74-2.00
EPS (diluted)-10.75-7.75-9.59-7.61-1.79
EBITDA-21.69-22.42-18.00-12.80-2.14
  EBIT00000
  +Depreciation & Amortization Expense1.021.523.062.872.62

Balance Sheet £1K

show content

Cash Flow £1K

show content

Analysis Data

show content

Intraday data is delayed by 15 minutes.

Name Latest Var
FTSE 100 5,338.38(c) -1.24%
FTSE 250 10,592.94(c) -0.77%
DOW INDUSTRIALS 12,492.67 -0.84%
HONG KONG HANG SENG INDIC 19,200.93 +0.00%
Nikkei 225 8,876.59(c) +0.00%